Paul O Mahoney
Registered User
- Messages
- 1,844
Well, he can only go on what information is available, his staff would have thought that we were getting x number of Astrazeneca vaccines and y number of Pfizer/BioNTech vaccines, those figures were based on agreements with the EU and what the EU agreed with manufacturers .So he doesn't really know then. It's like he is constantly "distracting" and talking about what might happen.
Companies like Pfizer and Moderna already sold future production batches to countries like the US and Israel who bought up large quantities from multiple producers without knowing which one will work and when it will be available. Also they were willing to pay much more.I hope that any company producing vaccines will not sell their production to any country who approaches them with a large cheque. I hope the EU have ordered enough, because these companies once they have fulfilled their contract will be free to sell to the highest bidder.
So he doesn't really know then. It's like he is constantly "distracting" and talking about what might happen.
I wonder why the reluctance, was it a desire to be seen as virtuous and not ouybidding poorer countries or something? In any case I doubt the member countries will thank them for their virtue. I can see the European medicines agency becoming obsolete after this as countries decide to go it alone or form their own alliances with like minded countries.The EU was very reluctant to do the same and started late and with smaller numbers ordered with that kind of contracts
Cyprus tries to get potential Israeli surplus vaccine - this might be even perhaps legal as they go to a government directly and not to a pharmaceutical company - Germany might do its own additional deal as well with BionTech/Pfizer but that would be "illegal"I wonder why the reluctance, was it a desire to be seen as virtuous and not ouybidding poorer countries or something? In any case I doubt the member countries will thank them for their virtue. I can see the European medicines agency becoming obsolete after this as countries decide to go it alone or form their own alliances with like minded countries.
And how would Pfizer make these additional vaccines given that its at full capacity now and doesn't have any more plants that can be used to produce more?Cyprus tries to get potential Israeli surplus vaccine - this might be even perhaps legal as they go to a government directly and not to a pharmaceutical company - Germany might do its own additional deal as well with BionTech/Pfizer but that would be "illegal"
But on the other hand I doubt a sanction mechanism is in place for side deals
The same like Israel is getting additional unscheduled deliveries - someone else will get delayed deliveries due to "technical problems".And how would Pfizer make these additional vaccines given that its at full capacity now and doesn't have any more plants that can be used to produce more?
Israel are getting unscheduled deliveries? I assume you can provide a link to this.The same like Israel is getting additional unscheduled deliveries - someone else will get delayed deliveries due to "technical problems".
So Israel did a deal with Pfizer for more vaccines in order to get detailed analysis on the vaccines effects.......is that "unscheduled deliveries "?The same like Israel is getting additional unscheduled deliveries - someone else will get delayed deliveries due to "technical problems".
On the case of Germany
Commission lets Germany off the hook for coronavirus vaccine solidarity breach
Germany confirms it will receive 30 million extra BioNTech/Pfizer doses outside of EU deal.www.politico.eu Germany secured 50 million vaccine doses from CureVac, BioNTech on top of EU supplies - document
The German government signed two preliminary deals with German biotech firms BioNTech and CureVac in the summer to secure 50 million doses of their COVID-19 vaccines, according to a health ministry document and an official.www.reuters.com
On Israel getting additional deliveries
.
(...)
Far from having ordered too little of the “American” vaccine, the EU sat back while the US and other countries stocked up on doses of a vaccine that was created and produced in a German lab. The EU is guilty not of protectionism, but of institutional inflexibility. The slow vaccine rollout in many European countries is the result of the EU’s failure to coordinate the interests of the various member states. Whereas some countries balked at the price of BioNTech’s mRNA vaccine, others were skeptical about its new gene-based technological underpinnings, and still others simply did not recognize the urgency of the situation, having assumed that the worst of the pandemic had already passed.
(...)
While the US, the United Kingdom, Japan, and Canada jostled last July and August to secure huge batches of the BioNTech vaccine, the EU initially placed its orders only with Sanofi and AstraZeneca, both of which subsequently admitted difficulties in clinical trials. Not until November – when journalists started asking pointed questions – did the EU strike its first deal for a batch of the BioNTech vaccine. This was followed in December and early January by further purchases, including from Moderna.
So Israel did a deal with Pfizer for more vaccines in order to get detailed analysis on the vaccines effects.......is that "unscheduled deliveries "?
They did a deal that Israel bought more vaccines in order for Pfizer to get data on the effectiveness of the vaccines.Speeding up deliveries - moving delivery dates forward means that the new earlier delivery date was not previously scheduled.
It is pretty clear that the company have not produced as much as they thought they would (which asks the question why is this suddenly announced as should have been blatantly clear to all parties before now) or they have sold supplies that were meant for the EU to another party. (Guess who)
They did a deal that Israel bought more vaccines in order for Pfizer to get data on the effectiveness of the vaccines.
Its a perfectly legitimate thing to do, and a very clever one.
Bourla identified that the Israeli health systems were the perfect place to distribute a lot of vaccines and get real data from the population.
There was nothing clandestine in doing this.
That's not going to happen. We, for example, would not have the expertise or budget to do what they do. The EU may have dropped the ball, we don't have enough information to say that for sure at the moment, but the EMA are not the reason for this current problem.I can see the European medicines agency becoming obsolete after this as countries decide to go it alone or form their own alliances with like minded countries.
Doesn't that highlight the difficulty and shortcomings of the EU in doing deals like this in an emergency situation. Israel was able to do a deal like this while taking some risk admittedly but clearly decided that it was worth doing. Even if the EU tried to act quickly it would get bogged down in consent and GDPR stuff. The EU is not agile and quick and countries resort to their own means when hit with an emergency as is happening again. The same thing happened during the migration crisis in 2015 it was every country for themselves and the EU protocols were abandoned even by Germany.They did a deal that Israel bought more vaccines in order for Pfizer to get data on the effectiveness of the vaccines.
Its a perfectly legitimate thing to do, and a very clever one.
Bourla identified that the Israeli health systems were the perfect place to distribute a lot of vaccines and get real data from the population.
There was nothing clandestine in doing this.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?